Bank of New York Mellon’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $49.2M | Buy |
565,666
+21,909
| +4% | +$1.32M | 0.01% | 1085 |
|
|
2026
Q1 | $21.9M | Sell |
543,757
-37,899
| -7% | -$1.42M | ﹤0.01% | 1487 |
|
|
2025
Q4 | $20.2M | Sell |
581,656
-19,843
| -3% | -$1.56M | ﹤0.01% | 1530 |
|
|
2025
Q3 | $50M | Sell |
601,499
-37,223
| -6% | -$2.69M | 0.01% | 1007 |
|
|
2025
Q2 | $46.9M | Buy |
638,722
+55,629
| +10% | +$4.03M | 0.01% | 1042 |
|
|
2025
Q1 | $66.6M | Sell |
583,093
-6,678
| -1% | -$406K | 0.01% | 799 |
|
|
2024
Q4 | $29.7M | Sell |
589,771
-15,637
| -3% | -$819K | 0.01% | 1334 |
|
|
2024
Q3 | $28M | Sell |
605,408
-72,736
| -11% | -$2.58M | 0.01% | 1381 |
|
|
2024
Q2 | $22M | Sell |
678,144
-45,878
| -6% | -$1.26M | ﹤0.01% | 1519 |
|
|
2024
Q1 | $18.2M | Sell |
724,022
-48,732
| -6% | -$1.15M | ﹤0.01% | 1629 |
|
|
2023
Q4 | $25.1M | Sell |
772,754
-62,073
| -7% | -$1.7M | 0.01% | 1476 |
|
|
2023
Q3 | $22.7M | Sell |
834,827
-19,425
| -2% | -$562K | 0.01% | 1484 |
|
|
2023
Q2 | $19M | Sell |
854,252
-73,659
| -8% | -$1.7M | ﹤0.01% | 1581 |
|
|
2023
Q1 | $20.1M | Buy |
927,911
+14,059
| +2% | +$308K | ﹤0.01% | 1540 |
|
|
2022
Q4 | $18.6M | Sell |
913,852
-84,940
| -9% | -$2.13M | ﹤0.01% | 1577 |
|
|
2022
Q3 | $25.6M | Buy |
998,792
+38,453
| +4% | +$1.03M | 0.01% | 1356 |
|
|
2022
Q2 | $22.8M | Sell |
960,339
-38,741
| -4% | -$844K | 0.01% | 1460 |
|
|
2022
Q1 | $22.5M | Sell |
999,080
-34,622
| -3% | -$736K | ﹤0.01% | 1599 |
|
|
2021
Q4 | $20.5M | Sell |
1,033,702
-57,883
| -5% | -$1.17M | ﹤0.01% | 1713 |
|
|
2021
Q3 | $21.5M | Buy |
1,091,585
+9,659
| +0.9% | +$202K | ﹤0.01% | 1690 |
|
|
2021
Q2 | $23.8M | Sell |
1,081,926
-317
| -0% | -$7.05K | ﹤0.01% | 1631 |
|
|
2021
Q1 | $25.7M | Sell |
1,082,243
-1,598
| -0.1% | -$42.7K | 0.01% | 1554 |
|
|
2020
Q4 | $28.4M | Sell |
1,083,841
-51,000
| -4% | -$1.07M | 0.01% | 1422 |
|
|
2020
Q3 | $19.8M | Sell |
1,134,841
-21,894
| -2% | -$349K | ﹤0.01% | 1482 |
|
|
2020
Q2 | $19.5M | Sell |
1,156,735
-6,127
| -0.5% | -$86.1K | 0.01% | 1459 |
|
|
2020
Q1 | $13.8M | Sell |
1,162,862
-51,488
| -4% | -$637K | ﹤0.01% | 1517 |
|
|
2019
Q4 | $14.7M | Sell |
1,214,350
-13,473
| -1% | -$188K | ﹤0.01% | 1745 |
|
|
2019
Q3 | $17.4M | Sell |
1,227,823
-43,945
| -3% | -$540K | ﹤0.01% | 1614 |
|
|
2019
Q2 | $14.2M | Sell |
1,271,768
-9,548
| -0.7% | -$106K | ﹤0.01% | 1763 |
|
|
2019
Q1 | $15M | Sell |
1,281,316
-60,625
| -5% | -$753K | ﹤0.01% | 1737 |
|
|
2018
Q4 | $17.9M | Buy |
1,341,941
+42,227
| +3% | +$558K | 0.01% | 1545 |
|
|
2018
Q3 | $18.2M | Buy |
1,299,714
+101,762
| +8% | +$1.42M | ﹤0.01% | 1686 |
|
|
2018
Q2 | $18.8M | Buy |
1,197,952
+11,001
| +0.9% | +$191K | 0.01% | 1638 |
|
|
2018
Q1 | $19.5M | Sell |
1,186,951
-349,529
| -23% | -$6.48M | 0.01% | 1583 |
|
|
2017
Q4 | $27.7M | Buy |
1,536,480
+587,457
| +62% | +$10.6M | 0.01% | 1381 |
|
|
2017
Q3 | $18.3M | Buy |
949,023
+22,673
| +2% | +$338K | 0.01% | 1618 |
|
|
2017
Q2 | $10.9M | Buy |
926,350
+41,703
| +5% | +$453K | ﹤0.01% | 1908 |
|
|
2017
Q1 | $9.7M | Buy |
884,647
+434,080
| +96% | +$3.81M | ﹤0.01% | 1990 |
|
|
2016
Q4 | $3.27M | Buy |
450,567
+110,889
| +33% | +$869K | ﹤0.01% | 2566 |
|
|
2016
Q3 | $2.21M | Buy |
339,678
+18,806
| +6% | +$109K | ﹤0.01% | 2701 |
|
|
2016
Q2 | $1.75M | Buy |
320,872
+49,807
| +18% | +$259K | ﹤0.01% | 2790 |
|
|
2016
Q1 | $1.27M | Sell |
271,065
-12,004
| -4% | -$46.8K | ﹤0.01% | 2923 |
|
|
2015
Q4 | $1.41M | Buy |
283,069
+12,664
| +5% | +$57.1K | ﹤0.01% | 2928 |
|
|
2015
Q3 | $1.02M | Sell |
270,405
-54,564
| -17% | -$277K | ﹤0.01% | 3176 |
|
|
2015
Q2 | $1.95M | Buy |
324,969
+76,999
| +31% | +$472K | ﹤0.01% | 2927 |
|
|
2015
Q1 | $1.39M | Sell |
247,970
-11,820
| -5% | -$42.8K | ﹤0.01% | 3102 |
|
|
2014
Q4 | $779K | Sell |
259,790
-16,892
| -6% | -$51.5K | ﹤0.01% | 3439 |
|
|
2014
Q3 | $741K | Sell |
276,682
-781
| -0.3% | -$2.07K | ﹤0.01% | 3465 |
|
|
2014
Q2 | $776K | Buy |
277,463
+26,616
| +11% | +$78.6K | ﹤0.01% | 3439 |
|
|
2014
Q1 | $1.09M | Buy |
250,847
+11,096
| +5% | +$38.8K | ﹤0.01% | 3228 |
|
|
2013
Q4 | $770K | Buy |
239,751
+8,683
| +4% | +$17.6K | ﹤0.01% | 3428 |
|
|
2013
Q3 | $367K | Buy |
231,068
+755
| +0.3% | +$1.33K | ﹤0.01% | 3624 |
|
|
2013
Q2 | $398K | Buy |
+230,313
| New | +$414K | ﹤0.01% | 3577 |
|
Other funds holding CORT
PA
EA
EMFAT
BTW
N
Bank of New York Mellon's CORT Position: Q2 2026 in Review
Bank of New York Mellon increased its Corcept Therapeutics (CORT) stake by 4% in Q2 2026, buying an estimated $1.32M and bringing the position to 565,666 shares worth $49.2M. The position accounts for 0.01% of the portfolio, ranked #1085.
Bank of New York Mellon first reported a position in CORT in Q2 2013 and has held it in 53 quarters since. The position peaked at $66.6M in Q1 2025. 223 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Bank of New York Mellon held 565,666 shares of Corcept Therapeutics worth $49.2M as of Q2 2026.
- Bank of New York Mellon bought 21,909 Corcept Therapeutics shares in Q2 2026, an estimated $1.32M.
- Corcept Therapeutics made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1085 holding.
- Bank of New York Mellon first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Corcept Therapeutics position peaked at $66.6M in Q1 2025.
- 223 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.